SCHEMBL21297481

SCHEMBL21297481

CC(S)c1cccc(-n2cnnc2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 2/20 0.35
HTR1D P28221 5/20 0.32
HTR1B P28222 5/20 0.32
LMNA P02545 1/20 0.31
NOTUM Q6P988 2/20 0.31
IDO1 P14902 1/20 0.31
RXRA P19793 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2B Q13224 1/20 0.31
PKM P14618 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
MEN1 O00255 1/20 0.30
HTT P42858 1/20 0.30
KMT2A Q03164 1/20 0.30
CBLB Q13191 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7994256 0.85 NOTUM (0.42) GABRG2GABRB3GABRA5GABRA3CYP1A2
SCHEMBL332300 0.73 HDAC4 (0.37) SMN1; SMN2HTT
SCHEMBL30015400 0.71 MGLL (0.47) GABRG2GABRB3GABRA5GABRA3CYP1A2
SCHEMBL10053917 0.71 HSP90AA1 (0.47) GABRG2GABRB3GABRA5GABRA3CYP1A2
SCHEMBL2658313 0.71 MGLL (0.47) GABRG2GABRB3GABRA5GABRA3CYP1A2
SCHEMBL18394093 0.69 GABRG2 (0.42) GABRG2GABRB3GABRA5GABRA3CYP1A2
SCHEMBL12841492 0.68 CYP1A2 (0.62) CYP1A2CYP2C9LMNANOTUMPKM
SCHEMBL20273069 0.68 HDAC4 (0.47) LMNANOTUMRXRAGRIN1GRIN2B
SCHEMBL859964 0.67 FGFR1 (0.47) GABRG2GABRB3GABRA5GABRA3LMNA
SCHEMBL30341093 0.67 MAPT (0.63) GABRG2GABRB3GABRA5GABRA3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10392375-B2 Heteroaryl compounds as IRAK inhibitors and uses thereof MERCK PATENT GMBH (DE) 2019-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10392375-B2 Heteroaryl compounds as IRAK inhibitors and uses thereof IRAK2, IRAK3, IRAK1 GABRG2 2241/4885GABRB3 1890/4885GABRA5 2556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.